Literature DB >> 5032150

Metabolic study and controlled clinical trials of rifampin.

S Sunahara, H Nakagawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5032150     DOI： 10.1378/chest.61.6_supplement.526

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  8 in total

1.  A comparison of rifampicin, ethambutol or PAS in short-term monotherapy in pretreated cavitary pulmonary tuberculosis.

Authors: 
Journal:  Pneumonologie       Date:  1975-12-12

2.  Mechanism of the inhibitory effect of PAS granules on the absorption of rifampicin: adsorption of rifampicin by an excipient, bentonite.

Authors:  G Boman; P Lundgren; G Stjernström
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

3.  Serum concentrations and bioavailability of rifampicin and isoniazid in combination.

Authors:  J C Garnham; T Taylor; P Turner; L F Chasseaud
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

4.  Plasma rifampicin assay by an improved solvent extraction technique.

Authors:  J B McConnell; H Smith; M Davis; R Williams
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

5.  Effect of rifampicin treatment on the metabolism of oestradiol and 17alpha-ethinyloestradiol by human liver microsomes.

Authors:  H M Bolt; H Kappus; M Bolt
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

6.  Determination of Rifampin Concentrations by Urine Colorimetry and Mobile Phone Readout for Personalized Dosing in Tuberculosis Treatment.

Authors:  Claire Szipszky; Daniel Van Aartsen; Sarah Criddle; Prakruti Rao; Isaac Zentner; Museveni Justine; Estomih Mduma; Stellah Mpagama; Mohammad H Al-Shaer; Charles Peloquin; Tania A Thomas; Christopher Vinnard; Scott K Heysell
Journal:  J Pediatric Infect Dis Soc       Date:  2021-03-26       Impact factor: 3.164

Review 7.  Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.

Authors:  M Strolin Benedetti; P Dostert
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

8.  Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study.

Authors:  Isaac Zentner; Hans P Schlecht; Lorna Khensouvann; Neo Tamuhla; Michele Kutzler; Vijay Ivaturi; Jotam G Pasipanodya; Tawanda Gumbo; Charles A Peloquin; Gregory P Bisson; Christopher Vinnard
Journal:  BMC Infect Dis       Date:  2016-06-01       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.